Stephen Ting is a Haematology clinician-scientist based at Alfred Health-Monash University. He is an active practising haematologist and a principal investigator studying self-renewal pathways of haematopoeitic and leukemia stem cells.

The research focus of Dr Ting aims to understand the molecular mechanisms governing haematopoietic and leukemia stem cell self-renewal. Using a functional screen he has identified novel endocytosis and cytoskeleton genes that enhance HSC activity. And via live cell videomicroscopy established Ap2a2 as an asymmetrically segregating protein in HSCs, thereby linking asymmetric cell division (ACD) to HSC self-renewal. He will utilise these discoveries to interrogate the fate and gene expression of daughter cells from ACD of HSCs. These genes shall also be studied for ex-vivo HSC expansion properties and whether their perturbation alters leukemia outcome in mouse models.

• Investigating asymmetric cell division in HSCs
• The mitotic spindle during haematopoietic and leukemia stem cell self-renewal
• The role of the cytoskeleton gene, Kif3 in ACD and T-ALL
• Ex vivo expansion of HSCs for transplantation

Lecturer in Human Pathology and Clinical Science courses

1994
6 months studying Mandarin in China at the Beijing Language and Cultural University.
2 months on Thailand-Myanmar border as a volunteer doctor

2013 - present

Leukemia Foundation: speaker at annual patient information symposiums

Consultant haematologist at Alfred Hospital, Melbourne, Victoria with inpatient and outpatient duties.

VMO consultant haematologist at Cabrini Hospital, Malvern, Victoria.